Bropirimine
Alternative Names: ABmFPP; ABPP; BRM; NSC 149027; Remisar; U 54461; U 54461S; U 56499Latest Information Update: 25 Sep 2021
At a glance
- Originator Pharmacia Corporation
- Developer Pharmacia Corporation; Yakult Honsha
- Class Antineoplastics; Pyrimidinones; Small molecules
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bladder cancer; Herpes simplex virus infections; Lymphoma
Most Recent Events
- 09 Apr 2002 Discontinued - Preregistration for Bladder cancer in USA (PO)
- 09 Apr 2002 No development reported - Phase-II for Bladder cancer in Japan (PO)
- 09 Apr 2002 No development reported - Phase-II for Herpes simplex virus infections in Japan (Topical)